This event, escalated to siemens is considered 'off-label use' because the product was sold to a home user and the system is not cleared for sale for patient at-home testing.The instrument has been returned to the distributor.Siemens has requested the instrument and strips to be returned for investigation.When the distributor was asked, if they were aware that this device is not for home use, the distributor stated that in fiscal year 2019, two systems were sold to them.They promoted the system on their website.After it was discovered that the system was sold to a private person, the promotion was removed from the website to prevent this in the future.The cause of this event is unknown.
|
A customer purchased an xprecia stride device on (b)(6) 2019 from an online distributor for home use.The xprecia stride system is not currently approved for home use.The distributor is identified as the initiator of the complaint to siemens.The patient takes coumadin regularly and should always be between 2.5 - 3.5 pt inr.First thing in the morning, the patient spit up blood.The patient already planned on going to the hospital due to spitting blood, but wanted to test his pt inr with xprecia stride anyway.The xprecia pt inr result was higher than the pt inr non-siemens hospital lab device.The patient was later diagnosed with a pulmonary embolism at the hospital.
|